Post by A*STAR - Agency for Science, Technology and Research

135,918 followers

šŸš€ š—•š˜‚š—¶š—¹š—±š—¶š—»š—“ š—® š— š—²š—±š—§š—²š—°š—µ š˜ƒš—²š—»š˜š˜‚š—æš—² š˜š—®š—øš—²š˜€ š—ŗš—¼š—æš—² š˜š—µš—®š—» š—Æš—æš—²š—®š—øš˜š—µš—æš—¼š˜‚š—“š—µ š—¶š—»š—»š—¼š˜ƒš—®š˜š—¶š—¼š—». Behind every #MedTech venture is a long journey of product development, clinical validation, manufacturing, regulatory approvals, scaling and commercialisation. Turning a promising #technology into a solution that can improve lives takes not only strong science, but also the right translation capabilities, industry partnerships and pathways to market. At A*STAR, we support innovators and enterprises in navigating this journey and translating promising technologies into globally competitive MedTech ventures. Through national platforms hosted by A*STAR, such as MedTech Catapult, medtechs gain access to translation capabilities, industry networks and venture-building support. These help accelerate the development and #commercialisation of innovative medical technologies. šŸ‘‰ Meet four medtechs supported by A*STAR that are developing innovative medical devices across #diagnostics, cardiovascular care, regenerative medicine and respiratory health. While each #technology addresses a different #healthcare need, they share a common ambition: bringing innovative medical solutions closer to the patients who need them. Collaborate with us to advance your MedTech innovation: https://lnkd.in/eiNQTNg4 HistoIndex | BYPASS SOLUTIONS SAS | CartiFuse | Meracle #SGMedTech #InnovatewithASTAR

Post contentPost contentPost content